Effects on haemoglobin of multi-micronutrient supplementation and multi-helminth chemotherapy: a randomized,

H Friis1, D Mwaniki, B Omondi

  • 1Research Department of Human Nutrition, Royal Veterinary and Agricultural University, Frederiksberg, Denmark. hfr@kvl.dk

Insights

Multi-micronutrient supplementation and anthelmintic treatment significantly improved hemoglobin levels in Kenyan schoolchildren. These interventions were effective regardless of initial hemoglobin or nutritional status, highlighting their potential for public health initiatives.

Area of Science:

  • Public Health Nutrition
  • Infectious Diseases
  • Pediatric Health

Background:

  • Iron deficiency anemia and helminth infections are prevalent in school-aged children, impacting cognitive development and overall health.
  • Schools offer a viable platform for delivering health interventions to large child populations.

Purpose of the Study:

  • To evaluate the impact of multi-micronutrient supplementation and multi-helminth chemotherapy on hemoglobin concentration in school children.
  • To assess the efficacy of school-based health delivery systems for these interventions.

Main Methods:

  • A randomized, placebo-controlled, double-blind, two-by-two factorial trial was conducted.
  • Participants received either multi-micronutrient supplements or a placebo, and anthelmintic treatment (albendazole and praziquantel) or a placebo.
  • Hemoglobin levels were measured at baseline and after 8 months.

Main Results:

  • Both multi-micronutrient supplementation and anthelmintic treatment independently increased hemoglobin levels (P=0.0002 and P=0.03, respectively).
  • Treatment effects were independent of baseline hemoglobin and nutritional status.
  • Anthelmintic treatment efficacy was linked to reduced Schistosoma mansoni and hookworm infection intensity.

Conclusions:

  • Multi-micronutrient supplementation and multi-helminth chemotherapy are effective in increasing hemoglobin concentration among school children.
  • School-based delivery systems can successfully implement these public health interventions.
Abstract

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...